AI - Booth AD

The Future of Biotechnology in the Age of Artificial Intelligence

Written by Megha Jasrotia · Guest Article The future of biotechnology and artificial intelligence is transforming medicine, agriculture, and industry. Biotechnology applies principles of biology, chemistry, and computational sciences to develop technologies that enhance human health, agricultural productivity, industrial efficiency, and environmental sustainability. Over the past century, biotechnology and artificial intelligence have evolved from traditional practices into a […]

Immune Checkpoint Inhibitors: a translational drug discovery case study

Leave a Comment / AI, biotechnology, Blog, Drug Discovery, LLM, Python / Anjali

Focus keyword: immune checkpoint inhibitors Immune checkpoint inhibitors (ICIs) revolutionized oncology by modulating immune regulation instead of directly targeting tumor cells. ICIs block CTLA-4 and PD-1/PD-L1 pathways that restrain T-cell activation. This case study shows immunology becoming real-world therapy. Nature immuno-oncology overview. Why Immune Checkpoint Inhibitors Matter Immune checkpoint inhibitors show the complete “bench-to-bedside” arc: Hypothesis → target validation → therapeutic

Immune Checkpoint Inhibitors: a translational drug discovery case study Read More »